Prothrombin consumption as an indicator of hemorrhagic phenotype in mild platelet function disorders.

Antoine Babuty Camille Debord Nicolas Drillaud Marion Eveillard Marc TrossaërtCatherine TernisienMarianne SigaudEmmanuelle CadorMarie Christine Bene Marc Fouassier

Published in: European journal of haematology (2023)

In this group of patients, there was an association between a pathological bleeding score and increased prothrombin consumption. This test could be used as an additional indicator of platelet function abnormality liable to be related to bleeding risk.

Keyphrases

end stage renal disease
ejection fraction

newly diagnosed
atrial fibrillation

peritoneal dialysis

patient reported